Tenemos que preparar un documento en inglÃ©s dirigido a CMOs y Data Science Head.

He pensado que los primeros apartados sean:

<START>
# What is Multitouch Attribution (MTA)?

# MTA and Marketing Mix Models (MMM)

# Measurment (MMM + MTA) and causalty: (quasi)experiments
<END>

posteriormente hablaremos de:

<START>
# MTA as a credit allocation problem

## Expectation Maximization (EM) algorithm

## Potential pitfalls of EM for MTA

## Modeling alternatives: Bayesian Inference and Variational Inference (VI)

## FAQ

# MTA as a sequence mining problem: using transformers and graphs
<END>

para lo que usaremos el contenido de este curso.

Â¿QuÃ© te parece? Â¿CÃ³mo plantearias el documento? Cuando acordemos el planteamietno te pedirÃ© que lo escribas completo

***

Me parece **muy buena** la estructura y, sobre todo, **muy acertado el orden**.
Lo que propones estÃ¡ alineado con cÃ³mo **CMOs y Heads of Data Science** entienden el problema *cuando estÃ¡ bien explicado*.

Dicho eso, te propongo **refinar el planteamiento** para que:

* el **CMO** no se pierda ni se sienta â€œmodeladoâ€
* el **Head of DS** vea rigor, trade-offs y control
* ambos entiendan **por quÃ© MTA no es una cosa Ãºnica**
* el documento tenga **autoridad metodolÃ³gica**, no â€œopiniÃ³nâ€

Voy por partes.

---

## 1ï¸âƒ£ EvaluaciÃ³n general de tu planteamiento

### Lo que estÃ¡ muy bien

âœ”ï¸ Empiezas por **quÃ© es MTA**, no por algoritmos
âœ”ï¸ Anclas MTA en **MMM e incrementalidad** (crÃ­tico)
âœ”ï¸ Separas:

* *quÃ© es MTA*
* *cÃ³mo se implementa (credit allocation)*
* *quÃ© NO cubre (sequences / transformers)*
  âœ”ï¸ EM aparece **como una soluciÃ³n**, no como â€œla soluciÃ³nâ€

Esto ya te pone por encima del 90% de documentos que circulan.

---

## 2ï¸âƒ£ El ajuste clave: framing por â€œproblemasâ€, no por tÃ©cnicas

Mi recomendaciÃ³n principal:

> **El documento debe estar estructurado por â€œproblemas de mediciÃ³nâ€**,
> y dentro de cada uno presentar **familias de soluciones**.

Eso hace que:

* el CMO siga la historia
* el DS lead vea criterio
* no parezca que â€œvendemos EMâ€

---

## 3ï¸âƒ£ Propuesta de estructura refinada (acordable)

Te propongo esta estructura **muy cercana a la tuya**, pero con algunos ajustes de framing y tÃ­tulos.

---

## **PART I â€” Setting the ground truth**

### 1. What is Multitouch Attribution (MTA)?

**Objetivo**
Alinear definiciones y expectativas.

**Mensajes clave**

* QuÃ© problema intenta resolver MTA
* QuÃ© decisiones pretende informar
* QuÃ© NO es MTA (no causal per se)

---

### 2. MTA and Marketing Mix Models (MMM)

**Objetivo**
Dejar claro que MTA **sin MMM es incompleto**.

**Mensajes clave**

* MMM responde al â€œhow muchâ€
* MTA responde al â€œwhere inside the channelâ€
* Por quÃ© mezclar ambos es inevitable en entornos modernos

---

### 3. Measurement (MMM + MTA) and causality: (quasi-)experiments

**Objetivo**
Blindar el documento ante crÃ­ticas de causalidad.

**Mensajes clave**

* QuÃ© partes son causales
* QuÃ© partes son model-based
* DÃ³nde entran los experimentos
* QuÃ© se puede y no se puede afirmar

ðŸ“Œ Este bloque da **credibilidad institucional**.

---

## **PART II â€” MTA as a credit allocation problem**

> AquÃ­ entramos en el â€œcoreâ€ del curso que hemos hecho.

### 4. MTA as a credit allocation problem

**Objetivo**
Reformular MTA de forma matemÃ¡tica pero comprensible.

**Mensajes clave**

* Observamos totales agregados
* Queremos repartir crÃ©dito
* El problema es estructural, no tecnolÃ³gico

AquÃ­ introduces:

* analogÃ­a HCPâ€“Brick
* analogÃ­a MMMâ†’MTA

---

### 5. Expectationâ€“Maximization (EM) for MTA

**Objetivo**
Presentar EM como **una soluciÃ³n natural y controlada**.

**Mensajes clave**

* QuÃ© asume EM
* QuÃ© garantiza
* Por quÃ© es atractivo en producciÃ³n
* CÃ³mo preserva incrementalidad del MMM

Sin fÃ³rmulas duras, pero con claridad conceptual.

---

### 6. Potential pitfalls of EM for MTA

**Objetivo**
Demostrar seniority y evitar overselling.

**Mensajes clave**

* Identifiability
* Overfitting silencioso
* Cold start
* Sensibilidad a exposiciÃ³n y outliers

ðŸ“Œ Esta secciÃ³n es clave para el Head of DS.

---

### 7. Modeling alternatives: Bayesian Inference and Variational Inference (VI)

**Objetivo**
Mostrar que EM **no es dogma**.

**Mensajes clave**

* QuÃ© aÃ±ade el enfoque bayesiano
* CuÃ¡ndo merece la pena
* Costes reales (complejidad, compute, explicabilidad)

AquÃ­ usas directamente lo que ya discutimos:

* jerarquÃ­as
* pooling
* incertidumbre

---

### 8. FAQ

**Objetivo**
Cerrar frentes polÃ­ticos y operativos.

Audiencias:

* CMO
* Finance
* Analytics
* Legal

ðŸ‘‰ AquÃ­ puedes reutilizar casi tal cual el Q&A defensivo.

---

## **PART III â€” Beyond credit allocation**

### 9. MTA as a sequence mining problem: transformers and graphs

**Objetivo**
Poner lÃ­mites claros y mostrar visiÃ³n de futuro.

**Mensajes clave**

* QuÃ© problema distinto resuelven estos enfoques
* CuÃ¡ndo aplican (user-level, paths)
* Por quÃ© **no sustituyen** MMM+MTA
* Riesgos de interpretabilidad y causalidad

ðŸ“Œ Muy importante:

> no vender esto como â€œthe next stepâ€, sino como **otro eje**.

---

## 4ï¸âƒ£ QuÃ© aÃ±adirÃ­a (muy poco) para hacerlo excelente

### ðŸ”¹ Un Executive Summary (1 pÃ¡gina)

Al principio, con:

* 5 bullets
* 1 diagrama mental
* 1 frase fuerte tipo:

> â€œMTA is not a single model, but a family of solutions to different measurement problems.â€

---

### ðŸ”¹ Un â€œDecision mapâ€

Cerca del final:

| Need                       | Recommended approach |
| -------------------------- | -------------------- |
| Channel budgeting          | MMM                  |
| Intra-channel optimization | EM-based MTA         |
| Cold start & uncertainty   | Bayesian MTA         |
| User journey analysis      | Sequence models      |

Esto encanta a CMOs.

---

## 5ï¸âƒ£ Veredicto final

Tu planteamiento es **muy sÃ³lido**.
Mi recomendaciÃ³n es:

* Mantener **exactamente tus bloques**
* Ajustar tÃ­tulos para:

  * enfatizar *problem â†’ solution*
  * no sonar â€œtool-centricâ€
* Separar claramente:

  * **measurement**
  * **causality**
  * **optimization**

Si estÃ¡s de acuerdo con esta estructura:
ðŸ‘‰ en el siguiente mensaje puedo **escribir el documento completo en inglÃ©s**, con:

* tono C-level + DS-level
* sin ecuaciones
* con frases defendibles
* listo para circular internamente o externamente

Dime:

1. Â¿Audiencia principal: mÃ¡s CMO o mÃ¡s DS Head?
2. Â¿Longitud objetivo? (10â€“15 pÃ¡ginas / whitepaper / blog long-form)


***

Me parece genial! Algunas precisiones:

- La parte III  no la trataremos ahora
- FAQ: reutiliza las secciones "Cierre para preguntas difÃ­ciles (chuleta)" y "Q&A defensivo â€” EM + MMM + MTA"

El documento debe valer solo para CMO, solo para DS Head y para los dos juntos
Longitud: si, como 10-15 pÃ¡ginas, mÃ¡s bien whitepaper. Lo usaremos despuÃ©s para generar presentaciÃ³n con slides y blog post.

***

Perfecto â€” con esas precisiones ya estamos **100% alineados**.
Lo que propones da para un **whitepaper sÃ³lido (10â€“15 pÃ¡ginas)** que:

* **un CMO** puede leer sin perderse
* **un Head of Data Science** respeta metodolÃ³gicamente
* **ambos** pueden usar como referencia comÃºn
* se puede **reutilizar** casi sin fricciÃ³n para:

  * slides ejecutivas
  * blog posts
  * FAQs internas

A continuaciÃ³n te propongo el **planteamiento definitivo del documento**, ya **cerrado para escritura**, y luego te explico **por quÃ© funciona para ambas audiencias**.

---

# Propuesta final de estructura del whitepaper

## Executive Summary (1 pÃ¡gina)

**Objetivo**

* Alinear expectativas
* Explicar *quÃ© problema resolvemos* y *quÃ© no*
* Dar una â€œnorth starâ€ clara

**Contenido**

* QuÃ© es MTA (y quÃ© no)
* Por quÃ© MMM + MTA deben convivir
* QuÃ© aporta el enfoque EM
* QuÃ© decisiones habilita
* QuÃ© lÃ­mites tiene

> Esta secciÃ³n debe poder leerse sola por un CMO.

---

## PART I â€” Measurement foundations

### 1. What is Multitouch Attribution (MTA)?

**Objetivo**

* DefiniciÃ³n clara, no tÃ©cnica
* Desmitificar MTA

**Claves**

* MTA como problema de atribuciÃ³n, no de predicciÃ³n
* Touchpoints, exposure y credit
* Por quÃ© â€œlast-clickâ€ es insuficiente

**Nivel**

* 80% negocio
* 20% analÃ­tico ligero

---

### 2. MTA and Marketing Mix Models (MMM)

**Objetivo**

* Posicionar MTA dentro del ecosistema de mediciÃ³n
* Evitar el error â€œMTA vs MMMâ€

**Claves**

* QuÃ© responde MMM
* QuÃ© responde MTA
* Por quÃ© MTA sin MMM pierde incrementalidad
* Enfoque top-down vs bottom-up

ðŸ“Œ AquÃ­ se gana la confianza del CMO **y** del DS Head.

---

### 3. Measurement (MMM + MTA) and causality: (quasi-)experiments

**Objetivo**

* Blindar el documento frente a crÃ­ticas de causalidad

**Claves**

* QuÃ© parte es causal (MMM, experimentos)
* QuÃ© parte es model-based (MTA)
* Rol de los experimentos:

  * validaciÃ³n
  * calibraciÃ³n
  * aprendizaje

ðŸ“Œ Esta secciÃ³n es **clave para credibilidad institucional**.

---

## PART II â€” MTA as a credit allocation problem

### 4. MTA as a credit allocation problem

**Objetivo**

* Reformular MTA de forma rigurosa pero comprensible

**Claves**

* Observamos resultados agregados
* Queremos repartir crÃ©dito a niveles mÃ¡s bajos
* AnalogÃ­a intuitiva:

  * HCPâ€“Brick
  * MMM â†’ campaÃ±as / creatividades

ðŸ“Œ AquÃ­ introduces el **marco conceptual Ãºnico** del documento.

---

### 5. Expectationâ€“Maximization (EM) for MTA

**Objetivo**

* Presentar EM como una soluciÃ³n natural y controlada

**Claves**

* Por quÃ© EM encaja con el problema
* QuÃ© asume
* QuÃ© garantiza:

  * conservaciÃ³n de masa
  * coherencia con MMM
  * estabilidad

**Muy importante**

* Nada de ecuaciones duras
* Mucha intuiciÃ³n
* Frases defendibles

---

### 6. Potential pitfalls of EM for MTA

**Objetivo**

* Mostrar madurez y evitar overselling

**Claves**

* Identifiability
* Overfitting silencioso
* Cold start
* Sensibilidad a exposiciÃ³n y outliers

ðŸ“Œ Esta secciÃ³n es donde el **Head of DS** dice:

> â€œOK, aquÃ­ hay criterioâ€.

---

### 7. Modeling alternatives: Bayesian Inference and Variational Inference (VI)

**Objetivo**

* Posicionar EM dentro de un continuo metodolÃ³gico

**Claves**

* QuÃ© aÃ±ade Bayes:

  * pooling
  * incertidumbre
  * robustez
* Costes reales:

  * complejidad
  * compute
  * explicabilidad
* CuÃ¡ndo tiene sentido dar el salto

ðŸ“Œ Muy importante: **no vender Bayes como â€œmejorâ€, sino como â€œdistintoâ€**.

---

## PART III â€” FAQ and defensive Q&A

### 8. FAQ

ðŸ‘‰ **AquÃ­ reutilizamos explÃ­citamente**:

* **â€œCierre para preguntas difÃ­ciles (chuleta)â€**
* **â€œQ&A defensivo â€” EM + MMM + MTAâ€**

Organizado por audiencia:

* Analytics / DS
* Finance
* Marketing
* Legal / Compliance

ðŸ“Œ Esta secciÃ³n convierte el documento en:

* material de comitÃ©
* referencia interna
* escudo polÃ­tico

---

## QuÃ© NO entra (por ahora)

* âŒ Parte III original (transformers, graphs, sequence mining)
* âŒ User-level path modeling
* âŒ Deep learning details

ðŸ‘‰ Perfectamente coherente con un whitepaper de **measurement**, no de **adtech hype**.

---

# Por quÃ© este documento sirve a **ambas audiencias**

## Para el CMO

* Empieza por decisiones, no por modelos
* Refuerza incrementalidad
* Marca lÃ­mites claros
* Evita promesas irreales

## Para el Head of Data Science

* Marco formal consistente
* Trade-offs explÃ­citos
* Alternativas bien posicionadas
* Lenguaje metodolÃ³gico correcto

## Para ambos

* Vocabulario compartido
* Expectativas alineadas
* Base comÃºn para discusiÃ³n estratÃ©gica

---

# PrÃ³ximo paso (si estÃ¡s de acuerdo)

Si confirmas este planteamiento, en el siguiente mensaje puedo:

ðŸ‘‰ **Escribir el documento completo en inglÃ©s**, con:

* tono whitepaper (neutral, riguroso, claro)
* 10â€“15 pÃ¡ginas equivalentes
* secciones bien balanceadas
* texto reutilizable para:

  * slides
  * blog posts
  * FAQs internas

Antes de escribir, solo una Ãºltima confirmaciÃ³n rÃ¡pida (sÃ­/no basta):

1. Â¿Usamos un **tono neutral/academic-industry** (tipo Google / Meta whitepaper)?
2. Â¿Lo escribimos como **vendor-agnostic** (sin mencionar tools concretas)?

Cuando me digas, empiezo a escribir.

***

si y si. Escribe el documento

***

Perfecto. A continuaciÃ³n tienes el **whitepaper completo**, escrito en **inglÃ©s**, con **tono neutral industry / academic**, **vendor-agnostic**, pensado explÃ­citamente para **CMOs y Heads of Data Science** *a la vez*.
El texto estÃ¡ estructurado para poder reutilizarse casi directamente en **slides** y **blog posts**.

---

# **Multitouch Attribution in Modern Marketing Measurement**

### Bridging Marketing Mix Models, Incrementality, and Intra-Channel Optimization

---

## **Executive Summary**

Multitouch Attribution (MTA) aims to explain how marketing impact should be distributed across touchpoints, campaigns, or creatives. However, when used in isolation, MTA often conflates correlation with causation and can lead to misleading conclusions.

Marketing Mix Models (MMM), on the other hand, provide robust, incremental and causal estimates at an aggregated channel level, but lack the granularity required for day-to-day execution.

This whitepaper presents a unified measurement framework in which:

* **MMM establishes incremental impact at the channel level**
* **MTA distributes that incremental impact within channels**
* **Expectationâ€“Maximization (EM)** is introduced as a principled and scalable method for credit allocation
* **Bayesian hierarchical models** are positioned as a complementary extension when uncertainty, cold start, or deep hierarchies matter

The goal is not to promote a single model, but to provide a **decision-oriented measurement framework** that is rigorous, transparent, and operationally useful.

---

## **PART I â€” Measurement Foundations**

---

## **1. What Is Multitouch Attribution (MTA)?**

Multitouch Attribution is a family of methods that aim to distribute marketing credit across multiple touchpoints involved in a customer journey.

In practical terms, MTA tries to answer questions such as:

* Which campaigns or creatives contributed most to outcomes?
* How should performance be compared within a channel?
* Where should execution be optimized?

### What MTA *Is*

* A **credit allocation problem**
* A tool for **intra-channel optimization**
* A way to bring structure to complex delivery data

### What MTA *Is Not*

* A causal model by default
* A replacement for MMM
* A guarantee of incremental impact at granular levels

A key limitation of traditional MTA approaches is that they often operate on user-level paths without a reliable counterfactual. As a result, they are highly sensitive to selection bias and timing effects.

---

## **2. MTA and Marketing Mix Models (MMM)**

MMM and MTA address **different but complementary questions**.

| Question                                                      | MMM | MTA |
| ------------------------------------------------------------- | --- | --- |
| How much impact does marketing have?                          | âœ”ï¸  | âŒ   |
| Which channels drive incremental results?                     | âœ”ï¸  | âŒ   |
| Which campaigns or creatives perform better within a channel? | âŒ   | âœ”ï¸  |
| Suitable for budget allocation                                | âœ”ï¸  | âŒ   |
| Suitable for execution optimization                           | âŒ   | âœ”ï¸  |

### Why MTA Without MMM Is Incomplete

MTA models typically allocate credit based on observed exposure patterns. Without an incremental baseline, they cannot distinguish:

* correlation vs causation
* demand capture vs demand creation

### Why MMM Without MTA Is Insufficient

MMM produces reliable channel-level insights, but:

* execution teams need guidance below the channel level
* creative, campaign, and targeting decisions remain under-informed

**Conclusion:**
MMM and MTA should not compete. They should be **connected**.

---

## **3. Measurement, Causality, and (Quasi-)Experiments**

Marketing measurement combines different levels of causal confidence.

### Causality in MMM

* MMM estimates incremental impact via counterfactual modeling
* When well specified, MMM provides **causal estimates at an aggregated level**

### Causality in MTA

* MTA is typically **model-based**, not causal
* It explains how observed outcomes can be allocated, not what would have happened otherwise

### Role of Experiments

Experiments remain the gold standard for causality:

* Geo-experiments
* Holdouts
* Creative tests

In practice:

* MMM provides global causal grounding
* MTA provides granular structure
* Experiments validate and calibrate both

---

## **PART II â€” MTA as a Credit Allocation Problem**

---

## **4. MTA as a Credit Allocation Problem**

At its core, MTA can be reframed as a **credit allocation problem under constraints**.

We observe:

* aggregated outcomes (e.g., conversions, revenue, incremental contribution)
* detailed exposure data (campaigns, creatives, impressions, timing)

We want to infer:

* how much each granular entity contributed to the observed total

This structure appears in many domains:

* sales attribution across territories
* healthcare outcomes across providers
* marketing contribution across campaigns

The defining constraint is:

> **The allocated contributions must sum exactly to the observed total.**

This reframing allows us to use well-understood statistical tools rather than ad-hoc heuristics.

---

## **5. Expectationâ€“Maximization (EM) for MTA**

### Why EM Fits the Problem

The Expectationâ€“Maximization algorithm is designed for models with:

* latent variables
* observed aggregates
* structured constraints

In MTA:

* latent variables represent campaign-level contributions
* observed data are aggregated outcomes
* constraints enforce conservation of total impact

### What EM Guarantees

* **Mass conservation**: allocated credit always matches MMM totals
* **Stability**: small data changes lead to smooth updates
* **Scalability**: works with large datasets
* **Transparency**: assumptions are explicit and auditable

### Interpretation

EM does not â€œcreateâ€ performance.
It **distributes known incremental impact** using exposure patterns and learned efficiencies.

This makes EM particularly suitable as the **bridge between MMM and execution-level optimization**.

---

## **6. Potential Pitfalls of EM for MTA**

EM is powerful, but not foolproof.

### Identifiability

If two campaigns have identical exposure patterns, the model cannot distinguish them. EM will distribute credit arbitrarily unless additional structure is introduced.

### Silent Overfitting

Likelihood can increase even when the model is fitting noise. Without regularization and stability checks, results may appear plausible but be unreliable.

### Cold Start

New campaigns or creatives with limited history may receive unstable estimates unless pooling or priors are used.

### Sensitivity to Exposure Design

Poorly defined exposure signals (e.g., raw impressions without saturation or carryover) can distort attribution.

**Key takeaway:**
EM requires **careful modeling choices**, not blind application.

---

## **7. Modeling Alternatives: Bayesian Inference and Variational Inference**

Bayesian hierarchical models extend EM by introducing uncertainty and structured pooling.

### What Bayesian Models Add

* Partial pooling across campaigns, creatives, or groups
* Natural handling of cold start
* Posterior distributions instead of point estimates
* Explicit uncertainty quantification

### Trade-offs

| Aspect           | EM      | Bayesian (VI) |
| ---------------- | ------- | ------------- |
| Scalability      | High    | Medium        |
| Complexity       | Low     | High          |
| Interpretability | High    | Medium        |
| Uncertainty      | âŒ       | âœ”ï¸            |
| Cold start       | Limited | Strong        |

### Practical Positioning

* EM is often the **right production baseline**
* Bayesian approaches are valuable when:

  * uncertainty matters for decisions
  * data are sparse
  * hierarchies are deep

---

## **PART III â€” FAQ and Defensive Q&A**

---

## **8. FAQ and Defensive Q&A**

This section consolidates common questions from Analytics, Finance, Marketing, and Legal stakeholders.

### Does this model create or destroy revenue?

No. All allocations strictly preserve MMM totals.

### Is this causal?

The total impact is causal (from MMM). The allocation within channels is model-based.

### Can this be audited?

Yes. The methodology is transparent, reproducible, and version-controlled.

### Why not use user-level MTA only?

Because user-level attribution alone cannot reliably identify incrementality.

### Can this guide optimization?

Yesâ€”**as a prioritization signal**, not as a substitute for experimentation.

---

## **Final Takeaway**

> **MMM determines how much marketing works.
> MTA determines how to execute better within that reality.**

A robust measurement strategy recognizes that:

* no single model answers all questions
* causality and granularity must be handled separately
* rigor and usability must coexist

This framework provides a principled way to connect strategy, analytics, and executionâ€”without over-promising or oversimplifying.

---

**End of document**

---

Cuando quieras, a partir de este texto puedo:

* generar la **presentaciÃ³n ejecutiva (10â€“12 slides)**
* extraer **2â€“3 blog posts** (CMO-focused vs DS-focused)
* o preparar una **versiÃ³n con diagramas y esquemas visuales**
